Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Ciprofloxacin/dexamethasone - Wikipedia

   en.wikipedia.org/wiki/Ciprofloxacin/dexamethasone

   Ciprodex, owned by Alcon Laboratories, Inc., is protected by multiple patents and will be restricted from generic manufacturing until 2025. [6] [7] Ciprodex is the number 1 topical antibiotic ear drop prescribed since 2007 by ENTs and pediatricians.

3. Alcon - Wikipedia

   en.wikipedia.org/wiki/Alcon

   Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [ 3 ] [ 4 ] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals , focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

4. Ciprofloxacin - Wikipedia

   en.wikipedia.org/wiki/Ciprofloxacin

   Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. [ 5] This includes bone and joint infections, intra-abdominal infections, certain types of infectious diarrhea, respiratory tract infections, skin infections, typhoid fever, and urinary tract infections, among others. [ 5]

5. Drug Coupons and Medicare: What You Need to Know - AOL

   www.aol.com/lifestyle/drug-coupons-medicare-know...

   To access these savings, there’s an annual membership fee of $20 for individuals and $35 for families. Kroger: The Kroger Rx Savings Club offers select medications for $6 or less for a 1-month ...

6. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

   www.aol.com/news/2010-08-26-novartis-alcon-buy...

   The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

7. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

   www.aol.com/news/2010-12-15-novartis-obtains...

   Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...

8. Moxifloxacin - Wikipedia

   en.wikipedia.org/wiki/Moxifloxacin

   Moxifloxacin is an antibiotic, used to treat bacterial infections, [4] including pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. [4] [5] It can be given by mouth, by injection into a vein, and as an eye drop. [5] Common side effects include diarrhea, dizziness, and headache. [4]

9. Novartis Aims to Beat $1.9B in Cost Savings By Year's End - AOL

   www.aol.com/2011/09/13/novartis-aims-to-beat-19b...

   The eye-care acquisition, which cost Novartis $51 billion, will deliver high single-digit to low double-digit sales growth, plus $350 million in cost It now expects more bang for its buck from Alcon.